{"id":1020101,"date":"2026-11-11T16:09:22","date_gmt":"2026-11-11T21:09:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/"},"modified":"2026-11-11T16:09:22","modified_gmt":"2026-11-11T21:09:22","slug":"delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/","title":{"rendered":"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment<\/b><\/p>\n<p class=\"bwalignc\"><i>\u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer\u201d to air Sunday, November 15 at 5:30 p.m. ET \/ 2:30 pm PT on Fox Business<\/i><\/p>\n<p>QUEENSBURY, N.Y.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nDelcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the Company will be featured on Health Uncensored with Dr. Drew in a segment titled \u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer.\u201d The segment is scheduled to air nationally on Sunday, November 15, 2026. A podcast is also expected to be released following the television broadcast.<\/p>\n<p><b>How to Watch<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Program:<\/b><i>Health Uncensored with Dr. Drew<\/i><\/li>\n<li><b>Episode title:<\/b><i>Mario &amp; Courtney Lopez: Health From the Inside Out<\/i><\/li>\n<li><b>Network:<\/b> FOX Business Network\n<\/li>\n<li><b>Air date:<\/b> Sunday, November 15, 2026\n<\/li>\n<li><b>Time:<\/b> 5:30 p.m. ET \/ 2:30 pm PT\n<\/li>\n<\/ul>\n<p>\nEpisodes of Health Uncensored with Dr. Drew are also available following broadcast on HealthUncensoredTV.com and the show\u2019s YouTube channel.<\/p>\n<p>\nThe program includes a discussion of percutaneous hepatic perfusion (PHP), a liver-directed approach that delivers high-dose chemotherapy directly to the liver while filtering the blood before it is returned to systemic circulation, limiting systemic exposure. Delcath\u2019s Hepatic Delivery System is designed for use in this procedure. The program takes viewers inside a treatment center.<\/p>\n<p>\nGerard Michel, Chief Executive Officer of Delcath Systems, Inc. and Dr. Sachin Modi, Consultant Interventional Radiologist at University Hospital Southampton in the United Kingdom are both featured in the segment. Utilizing Delcath\u2019s Hepatic Delivery System, University Hospital Southampton has performed more than 500 PHP procedures.<\/p>\n<p><b>About Delcath Systems, Inc.<\/b><\/p>\n<p>\nDelcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company\u2019s proprietary products, HEPZATO KIT<sup>\u2122<\/sup> (HEPZATO (melphalan) for Injection\/Hepatic Delivery System) in the United States and CHEMOSAT<sup>\u00ae<\/sup> Hepatic Delivery System for Melphalan in Europe, are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure during a percutaneous hepatic perfusion procedure.<\/p>\n<p>\nHEPZATO KIT is approved in the United States as a liver-directed treatment for adult patients with metastatic uveal melanoma (mUM) with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease, or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.<\/p>\n<p>\nFor more information about Delcath Systems, Inc., visit the Company\u2019s website.<\/p>\n<p><b>Important Safety Information<\/b><\/p>\n<p>\nHEPZATO KIT carries a boxed warning for severe peri-procedural complications and myelosuppression and is available only through a restricted program under the HEPZATO KIT REMS. Severe peri-procedural complications, including hemorrhage, hepatocellular injury and thromboembolic events, may occur. Myelosuppression can result in severe infection, bleeding or symptomatic anemia.<\/p>\n<p>\nPlease see the full Prescribing Information, including Boxed Warning, for <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hepzatokit.com&amp;esheet=54639661&amp;newsitemid=20261111448568&amp;lan=en-US&amp;anchor=HEPZATO+KIT&amp;index=1&amp;md5=78a49b0045937178e539aee4ce9c7e82\">HEPZATO KIT<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20261111448568\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261111448568\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations<br \/>\n<\/b><br \/>ICR Healthcare<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investorrelations@delcath.com\">investorrelations@delcath.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New York United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Medical Devices Entertainment FDA Biotechnology TV and Radio Internet Pharmaceutical Health Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment \u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer\u201d to air Sunday, November 15 at 5:30 p.m. ET \/ 2:30 pm PT on Fox Business QUEENSBURY, N.Y.&#8211;(BUSINESS WIRE)&#8211; Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the Company will be featured on Health Uncensored with Dr. Drew in a segment titled \u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer.\u201d The segment is scheduled to air nationally on Sunday, November 15, 2026. A podcast is also expected to be released following the television broadcast. How to Watch &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1020101","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment \u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer\u201d to air Sunday, November 15 at 5:30 p.m. ET \/ 2:30 pm PT on Fox Business QUEENSBURY, N.Y.&#8211;(BUSINESS WIRE)&#8211; Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the Company will be featured on Health Uncensored with Dr. Drew in a segment titled \u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer.\u201d The segment is scheduled to air nationally on Sunday, November 15, 2026. A podcast is also expected to be released following the television broadcast. How to Watch &hellip; Continue reading &quot;Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-11T21:09:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment\",\"datePublished\":\"2026-11-11T21:09:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/\"},\"wordCount\":529,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/\",\"name\":\"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-11-11T21:09:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment - Market Newsdesk","og_description":"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment \u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer\u201d to air Sunday, November 15 at 5:30 p.m. ET \/ 2:30 pm PT on Fox Business QUEENSBURY, N.Y.&#8211;(BUSINESS WIRE)&#8211; Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the Company will be featured on Health Uncensored with Dr. Drew in a segment titled \u201cPrecision Oncology: Changing the Game for Metastatic Liver Cancer.\u201d The segment is scheduled to air nationally on Sunday, November 15, 2026. A podcast is also expected to be released following the television broadcast. How to Watch &hellip; Continue reading \"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-11T21:09:22+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment","datePublished":"2026-11-11T21:09:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/"},"wordCount":529,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/","name":"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-11-11T21:09:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261111448568r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-be-featured-on-health-uncensored-with-dr-drew-in-segment-highlighting-advances-in-liver-directed-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Delcath Systems to Be Featured on \u201cHealth Uncensored with Dr. Drew\u201d in Segment Highlighting Advances in Liver-Directed Cancer Treatment"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1020101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1020101"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1020101\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1020101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1020101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1020101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}